QualityDipStocks / Technology · Semiconductors
Ichor ICHR
Outside our quality screen, so we don’t track its dips. It’s 67% below its 52-week high.
Outside our quality screen, 32% under its Market Value. No fair value estimate for now: its free cash flow is negative.
Worth knowing
- Deepest drop from a 52-week high in over 3 years
- Down 68% from its 52-week high while revenue grew 15%
From the data on this page, as of the last close. How we pick these
- Fair value est.
- n/a
- Market Value
- $54.55price −32%
- Off 52-wk high
- −67%
- Risk vs market
- Highbeta 3.89
52-week range 23% of the way from its 52-week low to its high
Price $36.84Market Value $54.55
5 bullish · 5 bearish See why
Repriced or dip?
Dip: business intact
The price is 67% below its 52-week high (Jun 30), but the business held up: revenue +15.0%, revenue growth rate +7.7 pts, earnings per share turned to a profit.
Some numbers held up (revenue +15.0%, revenue growth rate +7.7 pts, earnings per share turned to a profit), others slipped (shares outstanding more shares, each owns less). The price is 67% below its 52-week high.
The price is 67% below its 52-week high, and the business changed too: shares outstanding more shares, each owns less.
Within 10% of its 52-week high, so there is no dip to judge yet.
The evidence 8 numbers, high vs now
- Revenue, last 12 months$959M → $1.1B (+15.0%)held up
- Revenue growth rate+7.5% → +15.2% a year (+7.7 pts)held up
- Earnings per share, 12 monthsturned to a profitheld up
- Operating margin−3.8% → 1.7% (+5.4 pts)held up
- Shares outstanding+9.8% (more shares, each owns less)changed
- Net cash (cash minus debt)+9.1% of market cap since the highheld up
- Stock vs its sector (Technology)stock −67%, sector median +1% since Jun 30changed
- Price fall vs business numbersprice −67%, revenue/EPS/FCF median +15% (shown, not scored)
Business numbers as reported at the high (12 months to Mar 27, 2026) vs the latest filing (12 months to Sep 25, 2026). Each measure is scored from −1 (business changed) to +1 (business intact) and weighted: revenue, earnings per share, free cash flow, operating margin, revenue growth rate, share count, net cash and the move vs its sector. 60 or more reads as a dip, 40 or less as a repricing. Analyst estimates are not in our data, so they are not used. How to read it
Data-based read, not advice.
Priced in
How much growth the market assumed at the 52-week high, the low and today (a reverse DCF).
Now: P/E 398.3×.
| High | Low | Now | |
|---|---|---|---|
| Price | $112.28Jun 30 | $14.25Nov 20 | $36.84 |
| Implied growth | n/a | n/a | n/a |
| P/E | n/a | n/a | 398.3× |
| EV/Sales | 4.1× | 0.5× | 1.2× |
What this means: a lower P/E than at the high means you pay less for each dollar of profit than buyers did then.
How it’s computed
Reverse DCF: the same 10-year free-cash-flow model as our fair value estimate (9.5% discount rate, growth for years 1–5 fading to 3% by year 10, 3% after), solved for the growth that makes it equal the market value at each price. For the high and the low we use only the filings that were public on that day, so nothing from a later report leaks back. Market value = that close × diluted shares. P/E = market value / 12-month net income; Price / FCF = market value / 12-month free cash flow; EV / Sales = (market value + debt − cash) / 12-month revenue. Hidden when the share count moved over 20% (split, merger), free cash flow is negative, or the company reports in another currency.
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
No estimate for ICHR: negative free cash flow. We’d rather show nothing than a made-up number.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much ICHR moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Swings much more than the market, and its own price swings are 7.6× the S&P 500’s.
- Beta vs S&P 500
- 3.89
- Volatility
- 98% vs 13% SPY
- Correlation SPY
- 0.51
- Correlation QQQ
- 0.60
How it ranks
Where ICHR stands vs every one of the 2,467 stocks we cover that has the number. Longer bar = better.
Not in the top quarter on any of these 4 measures
- Free cash flow yield−4.8% · free cash flow vs market capLowest 9%of 1,690
- Revenue growth, last 12 months+15% · vs the 12 months beforeTop 33%of 2,184
- Operating margin1.7% · of sales kept as operating profitLowest 19%of 1,549
- Return on invested capital1.5% · profit per dollar of capitalLowest 15%of 1,001
From SEC filings and our fair value estimate model. A ranking, not advice.
Valuation details
MV $54.55
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 5 of 5
Balance sheetNet cash of $94M: cash and short-term investments exceed debt (Sep 25, 2026).
GrowthSales grew 15% to $1.1B over the last 12 months vs the 12 months before (SEC filings).
Balance sheetDebt / equity of 0.1×, below the 0.4× median for the 163 Technology companies we cover.
ValuationPrice / book of 1.6×, below the 5.0× median for the 312 Technology companies we cover.
ValuationTrades 32.5% below its Market Value of $54.55, the average price paid since the Aug 3 filing.
Top bearish points 5 of 5
ValuationFree cash flow is negative (−$67M over the last 12 months), so there’s no cash-flow value under the price.
Cash returnsShare count up 11.1% in a year: existing holders are being diluted.
GrowthSales shrank 10% a year from FY2022 to FY2025.
QualityDoesn’t pass our quality screen: no positive free cash flow; ROE under 12% and ROIC under 10%.
RiskSwings hard: beta 3.89 vs the S&P 500 and 98% yearly volatility (SPY 13%).
All fundamentals
FCF yield -4.8% · ROE 0% · Sales +15%
Valuation
- P/E
- n/an/m: earnings near zero (P/E above 300)
- Price / FCF
- n/anegative free cash flow
- FCF yield
- −4.8%
- EV / EBITDA
- 25.8×
- Price / sales
- 1.27×
- Price / book
- 1.58×
- Market cap
- $1.4Blisted
- Enterprise value
- $1.3B
Growth
- Revenue, 12 months
- $1.1B
- Sales growth, 12 months
- +15.2%vs the 12 months before
- Sales growth, 3 yrs
- −9.5%/yrfrom FY2022
- Diluted EPS, 12 months
- $0.07
- EPS growth, last FY
- n/afewer than two years of diluted EPS
- Net income, 12 months
- $4M
- Net income growth
- n/anot reported in its SEC filings
Profitability
- Gross margin
- 13.3%
- Operating margin
- 1.7%
- Net margin
- 0.3%
- FCF margin
- −6.1%
- Return on equity
- 0%
- Return on invested capital
- 1%
Balance sheet
- Cash & short-term inv.
- $214M
- Total debt
- $119M
- Net cash
- $94M
- Debt / equity
- 0.13×
- Interest coverage
- 3.5×operating income / interest
Cash flow & returns
- Free cash flow, 12 months
- −$67M
- FCF growth, 12 months
- n/anot reported in its SEC filings
- Dividend yield
- n/ano dividend payments tagged
- Payout ratio
- n/anot reported in its SEC filings
- Buybacks, 12 months
- n/anot reported in its SEC filings
- Share count, 1 year
- +11.1%diluted shares vs a year ago
- Stock-based comp
- $15M
Trailing 12 months to Sep 25, 2026; balance sheet at Sep 25, 2026. From Ichor’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
FCF $-0.1B · Sales +23%
- Free cash flow, 12 months−$0.1B
- Free-cash-flow yield-4.8%
- Gross margin13%
- Operating margin3%
- Return on invested capital4%
- Return on equity−5%
- Sales growth (latest quarter vs year-ago quarter)+23%
- Net debt / EBITDA−2.8×
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $36.84
- 52-wk lowlowest close, 1 year$14.25−61.3%
- PriceMon Nov 2 close$36.84you are here
- Market Valueavg paid since Aug 3$54.55+48.1%
- 52-wk highhighest close, 1 year$112.28+204.8%
Momentum & 52-week range
RSI 30 · 5 days −3.2%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
ICHR is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on Ichor in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 5:14 PM ET.
Compare with peers
Closest in size in Semiconductors
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.